Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Implementing Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease USA Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk IndividualsRelease Date:Quality Improvement Vaccines Japan Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious DiseasesRelease Date:Education Vaccines Japan Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical CancerRelease Date:Education Oncology USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Research Vaccines Italy Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOSRelease Date:Research Oncology USA Optimizing Early Biomarker Testing to Guide Clinical Decision-Making in Colorectal Cancer Across Latin AmericaRelease Date:Education Oncology Argentina, Brazil, Chile, Colombia, Mexico, Peru Optimizing Maternal RSV Immunization Delivery: A Systems-Based QI Initiative to Improve Uptake, Equity, and Newborn OutcomesRelease Date:Quality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipEducation Oncology USA Improving Venous Thromboembolism (VTE) Diagnosis and Treatment with Primary Care Settings- A Quality Improvement ProjectRelease Date:Partner: American Academy of Family PhysiciansQuality Improvement Internal Medicine USA Title Grant Type Focus Area Country Application Due Date Life-Long Learning and Implementation of Education in Pain Associated with Osteoarthritis (Europe EFIC)Quality Improvement Internal Medicine Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, France, Metropolitan, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Moldova, Republic of, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom Use of Biosimilar Agents in Inflammatory ConditionsRelease Date:Education Inflammation & Immunology USA Diagnosis of Invasive Fungal InfectionsRelease Date:Education Hospital Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Cocos (Keeling) Islands, Colombia, Comoros, Congo, Congo, The Democratic Republic, Cook Islands, Costa Rica, Cote D'ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, France, Metropolitan, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-bissau, Guyana, Haiti, Heard and Mc Donald Islands, Holy See (Vatican City State), Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Korea, Korea, Democratic People's Rep, Kuwait, Kyrgyzstan, Lao People's Democratic Republ, Latvia, Lebanon, Lesotho, Liberia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, The Former Yugoslav, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Federated States o, Moldova, Republic of, Monaco, Mongolia, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russia, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadin, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Singapore, Slovakia (Slovak Republic), Slovenia, Solomon Islands, Somalia, South Africa, South Georgia and the South Sa, Spain, Sri Lanka, St. Helena, St. Pierre and Miquelon, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tajikistan, Tanzania, United Republic of, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States Minor Outlying I, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (U.S.), Wallis and Futuna Islands, Western Sahara, Yemen, Yugoslavia, Zambia, Zimbabwe Adoption of Biosimilars in OncologyRelease Date:Partner:The National Comprehensive Cancer Network® (NCCN)
Research Oncology USA Improving Disparities in Rheumatoid Arthritis Health Care in Post COVID-19 Era in memory of Cinzia CurialeRelease Date:Education Inflammation & Immunology Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom Management of Non-Communicable Diseases (NCD) for Health Care ProvidersRelease Date:Education Internal Medicine Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Holy See (Vatican City State), Hungary, Iceland, Ireland, Italy, Japan, Kazakhstan, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Turkey, USA, Ukraine, United Kingdom Continuity of Care: Education for Rheumatology PatientsRelease Date:Education Inflammation & Immunology USA Assessment of on-time immunization coverage in children under 2 years of age in CanadaRelease Date:Research Vaccines Canada Optimal Early Therapy Management in CMLRelease Date:Quality Improvement Oncology Canada, USA Addressing Racial Disparities in Cancer CareQuality Improvement Oncology USA Addressing Knowledge Gaps in Growth Hormone DeficiencyRelease Date:Education Rare Disease USA Telehealth in Postmenopausal Patient CareRelease Date:Education Internal Medicine USA Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFPRelease Date:Quality Improvement Inflammation & Immunology Canada, USA ADVANCE: Global Awards for Advancing Chronic Pain ResearchResearch Internal Medicine All Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 EraRelease Date:Quality Improvement Inflammation & Immunology United Kingdom New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)Release Date:Partner: Merck KGaA Darmstadt, Germany and EMD SeronoEducation Oncology France, Germany, Italy, Spain, USA, United Kingdom Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology All Remote Mentoring Programs in RCCRelease Date:Education Oncology USA Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)Release Date:Partner: The Sharing Progress in Cancer Care (SPCC)Quality Improvement Oncology All Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision MakingRelease Date:Education Oncology Canada, USA NSCLC Oncogene Driver Considerations in Testing & TreatmentRelease Date:Education Oncology USA Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)Release Date:Education Inflammation & Immunology Canada, USA Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia AreataRelease Date:Education Inflammation & Immunology France, Germany Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology All Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)Release Date:Education Oncology All Biosimilars in Hematologic Malignancies & Supportive CareRelease Date:Education Oncology All The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)Release Date:Education Hospital All Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast CancerRelease Date:Education Oncology USA Advances in Atopic Dermatitis for Advanced PractitionersRelease Date:Education Inflammation & Immunology USA 2020 RD US- Next Generation PET Imaging for ATTR-CMResearch Rare Disease USA Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant ProgramRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence TreatmentEducation Internal Medicine China, Malaysia, Taiwan, Thailand 4th Quality Improvement initiatives optimizing AF and VTE management in CanadaQuality Improvement Internal Medicine Canada 2021 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA 2021 Ulcerative Colitis Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Adoption of Biosimilars in OncologyRelease Date:Quality Improvement Oncology Canada 2021 Global Hemophilia ASPIRERelease Date:Research Rare Disease All Inflammatory and Immune-Mediated Dermatologic DisordersRelease Date:Research Inflammation & Immunology USA Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant LipoproteinsRelease Date:Education Internal Medicine All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World ExperienceRelease Date:Research Inflammation & Immunology Italy Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)Release Date:Research Inflammation & Immunology All 2021 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2021 Rheumatology FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2021 Fellowship for Inflammatory Dermatological DiseasesRelease Date:Fellowship Inflammation & Immunology USA